NPOs have superior potency within the μ-opioid receptor and an understudied propensity for adverse health and fitness outcomes. Nitazenes are structurally unrelated to fentanyl, but have been located for being as much as one thousand-fold far more potent than morphine.1 "NPOs have higher μ-opioid receptor activation than morphine and fentanyl, https://whitneyq641mwe0.blogoscience.com/profile